News and Announcements
Prescient Fully Underwritten Up To Target Amount of $1.03 million
- Published October 30, 2015 12:00PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th October 215, ASX Announcement
- Funds to drive next stage development of promising lead drug asset PTX-200
- SPP fully underwritten by Patersons Securities up to the target amount of $1.03 million and anticipated to fund key activities and milestones to Q3 2016
- Multiple value creation points in next 12 months from PTX-200 trials in breast, ovarian cancers and Acute Myeloid Leukemia
Cancer drug development company Prescient Therapeutics Limited (ASX:PTX) (Company) is pleased to announce a Share Purchase Plan (SPP) fully underwritten up to the target amount of $1.03 million to underpin next stage development of its lead oncology assets.
The SPP provides the opportunity for existing shareholders to subscribe for up to $15,000 in new fully paid ordinary share (New Shares) without inuring brokerage or other transaction costs.
To read the full announcement, please click here.
To read the Share Purchase Plan, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
